Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-19-008328
Filing Date
2019-04-30
Accepted
2019-04-30 16:23:05
Documents
4
Period of Report
2019-06-13
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A dffn20190429_def14a.htm DEF 14A 486147
2 dffn20190429_def14aimg001.jpg GRAPHIC 10370
3 p1.jpg GRAPHIC 88688
4 p2.jpg GRAPHIC 64968
  Complete submission text file 0001437749-19-008328.txt   713446
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37942 | Film No.: 19782097
SIC: 2834 Pharmaceutical Preparations